Yuksel, H.C.; Acar, C.; Sahin, G.; Celebi, G.; Tunbekici, S.; Karaca, B.S.
LASSO-Driven Selection of Biochemical and Clinical Markers for Primary Resistance to PD-1 Inhibitors in Metastatic Melanoma. Medicina 2025, 61, 1559.
https://doi.org/10.3390/medicina61091559
AMA Style
Yuksel HC, Acar C, Sahin G, Celebi G, Tunbekici S, Karaca BS.
LASSO-Driven Selection of Biochemical and Clinical Markers for Primary Resistance to PD-1 Inhibitors in Metastatic Melanoma. Medicina. 2025; 61(9):1559.
https://doi.org/10.3390/medicina61091559
Chicago/Turabian Style
Yuksel, Haydar C., Caner Acar, Gokhan Sahin, Gulcin Celebi, Salih Tunbekici, and Burcak S. Karaca.
2025. "LASSO-Driven Selection of Biochemical and Clinical Markers for Primary Resistance to PD-1 Inhibitors in Metastatic Melanoma" Medicina 61, no. 9: 1559.
https://doi.org/10.3390/medicina61091559
APA Style
Yuksel, H. C., Acar, C., Sahin, G., Celebi, G., Tunbekici, S., & Karaca, B. S.
(2025). LASSO-Driven Selection of Biochemical and Clinical Markers for Primary Resistance to PD-1 Inhibitors in Metastatic Melanoma. Medicina, 61(9), 1559.
https://doi.org/10.3390/medicina61091559